The crypto miner turned infrastructure player has acquired two high-capacity sites in Kentucky and Maryland, boosting its total planned capacity to 2.8 gigawatts as it capitalizes on the soaring demand for compute and power.
Israeli Prime Minister Benjamin Netanyahu convened with senior U.S. diplomat Steve Witkoff and top Israeli security officials on Tuesday, as Washington and Tehran prepare for a critical round of nuclear negotiations in Turkey this Friday.
Legend Biotech shares have plummeted nearly 50% in three months, erasing billions in market value and forcing investors to question whether the selloff is an overreaction or a prudent reassessment of the CAR-T leader's long-term prospects.
Darden Restaurants is winding down its Bahama Breeze brand, closing 14 locations and converting another 14 to other concepts within its portfolio, as the casual dining sector continues to face significant headwinds.
The National Rifle Association is urging Congress to pass concealed carry reciprocity legislation following sharp criticism from U.S. Attorney Jeanine Pirro, who vowed to prosecute anyone bringing firearms into Washington, D.C., regardless of permits.
As Europe's industrial decarbonization push intensifies, major offshore carbon capture and storage (CCS) projects are moving from blueprint to reality. From the North Sea to the Mediterranean, new infrastructure is taking shape, setting the stage for critical discussions at the upcoming DECARBON 2026 congress in Austria.
Midstream giant MPLX reports robust 2025 results, announces a 12.5% distribution increase and outlines a $2.4 billion capital plan for 2026 focused on Permian and Marcellus basins, betting on long-term natural gas and NGL demand.
Despite a Complete Response Letter for its epinephrine film Anaphylm, Aquestive Therapeutics receives a vote of confidence from Leerink Partners. The firm highlights a 'silver lining,' noting the FDA's requests appear addressable without major new studies, setting a defined, though delayed, route to potential U.S. approval.
Panasonic Energy announced its De Soto facility is scaling up to 50% operational capacity within months, with construction on a major second wing now underway, signaling robust growth amid a shifting EV policy landscape.
Amid a recent market sell-off, ARK Invest's Cathie Wood executed one of her firm's busiest trading days of the year, doubling down on three high-growth names she sees as undervalued.
Pilgrim Partners Asia significantly reduced its holding in the iShares Ethereum Trust ETF as Ether's price struggles, highlighting institutional risk management in volatile digital asset markets.
Cotton futures edged higher in Tuesday morning trading, recovering from Monday's losses, as markets reacted to news of a potential U.S.-India trade deal involving tariff reductions and major purchase commitments.
The iconic New York bakery appoints former Jamba and Jimmy John's executive Nathan Louer to lead its next growth phase, while longtime leader Bobbie Lloyd transitions to chief brand officer.
The Walt Disney Company has named Josh D'Amaro, the executive behind its thriving parks and experiences division, as its next Chief Executive Officer, succeeding Bob Iger in March. In a major creative reshuffle, Dana Walden assumes a new, powerful role overseeing all content.
Vera Therapeutics elevates Matt Skelton to Chief Commercial Officer, signaling a strategic shift towards commercialization as its lead drug candidate, atacicept for IgA nephropathy, undergoes FDA Priority Review with a PDUFA date set for July 2026.
General Mills faces a pivotal moment as it appoints a new independent director and updates governance bylaws, while simultaneously expanding a voluntary recall of Pillsbury Pizza Pops in Canada over potential E. coli contamination. These parallel developments underscore the balancing act between strategic oversight and operational risk management for the consumer staples giant.
Bloom Energy secures a multi-billion dollar, multi-year agreement with American Electric Power, marking its largest commercial deal to date. The partnership promises a major rollout of Bloom's fuel cell technology but arrives as the company's stock faces intense scrutiny over its recent meteoric rise and long-term valuation.
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing expansion for its injectable weight loss therapies, alongside forging two new research collaborations targeting hearing loss and autoimmune diseases, as its stock continues a meteoric rise.
Once a popular and practical finish, pebbledash render is now seen by many buyers as a dated eyesore that can knock thousands off a property's price. But is removal always the answer?
New data reveals companies embracing structured flexibility are growing significantly faster and attracting deeper talent pools than their office-mandate rivals, reshaping the post-pandemic competitive landscape.
